Coherus BioSciences, Inc. (CHRS)
USD 0.78
(-4.73%)
USD 0.78
(-4.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 377.95 Million USD | -7.25% |
| 2022 | 407.51 Million USD | 4671.07% |
| 2021 | -8.91 Million USD | 93.5% |
| 2020 | -137.13 Million USD | -19199.58% |
| 2019 | 718 Thousand USD | -97.66% |
| 2018 | 30.73 Million USD | 220.53% |
| 2017 | -25.5 Million USD | -3.28% |
| 2016 | -24.69 Million USD | 84.4% |
| 2015 | -158.22 Million USD | -5.21% |
| 2014 | -150.39 Million USD | -325.43% |
| 2013 | -35.35 Million USD | -175.96% |
| 2012 | -12.81 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 221.38 Million USD | -41.42% |
| 2024 Q2 | 139.1 Million USD | -37.17% |
| 2023 Q4 | 377.95 Million USD | -5.14% |
| 2023 Q2 | 406.33 Million USD | -10.79% |
| 2023 Q1 | 455.47 Million USD | 11.77% |
| 2023 Q3 | 398.42 Million USD | -1.95% |
| 2023 FY | 377.95 Million USD | -7.25% |
| 2022 Q3 | 193.91 Million USD | 24.08% |
| 2022 Q4 | 407.51 Million USD | 110.15% |
| 2022 FY | 407.51 Million USD | 4671.07% |
| 2022 Q1 | 104.66 Million USD | 1274.02% |
| 2022 Q2 | 156.28 Million USD | 49.32% |
| 2021 Q2 | 88.2 Million USD | -44.2% |
| 2021 Q4 | -8.91 Million USD | -115.31% |
| 2021 FY | -8.91 Million USD | 93.5% |
| 2021 Q3 | 58.23 Million USD | -33.98% |
| 2021 Q1 | 158.06 Million USD | 215.26% |
| 2020 Q1 | -3.1 Million USD | -531.89% |
| 2020 FY | -137.13 Million USD | -19199.58% |
| 2020 Q4 | -137.13 Million USD | -213.06% |
| 2020 Q3 | 121.29 Million USD | -31.64% |
| 2020 Q2 | 177.44 Million USD | 5822.28% |
| 2019 FY | 718 Thousand USD | -97.66% |
| 2019 Q1 | 101.64 Million USD | 230.7% |
| 2019 Q2 | 71.24 Million USD | -29.91% |
| 2019 Q3 | 12.65 Million USD | -82.24% |
| 2019 Q4 | 718 Thousand USD | -94.33% |
| 2018 Q4 | 30.73 Million USD | 1940.9% |
| 2018 FY | 30.73 Million USD | 220.53% |
| 2018 Q3 | 1.5 Million USD | 105.44% |
| 2018 Q2 | -27.67 Million USD | -238.74% |
| 2018 Q1 | 19.94 Million USD | 178.21% |
| 2017 Q3 | -34.29 Million USD | -224.43% |
| 2017 Q2 | 27.56 Million USD | 213.24% |
| 2017 Q1 | -24.34 Million USD | 1.42% |
| 2017 FY | -25.5 Million USD | -3.28% |
| 2017 Q4 | -25.5 Million USD | 25.65% |
| 2016 FY | -24.69 Million USD | 84.4% |
| 2016 Q2 | -121.28 Million USD | -51.17% |
| 2016 Q4 | -24.69 Million USD | 58.67% |
| 2016 Q1 | -80.23 Million USD | 49.29% |
| 2016 Q3 | -59.73 Million USD | 50.75% |
| 2015 Q3 | -153.69 Million USD | 25.42% |
| 2015 Q2 | -206.08 Million USD | -79.0% |
| 2015 Q1 | -115.13 Million USD | 23.44% |
| 2015 FY | -158.22 Million USD | -5.21% |
| 2015 Q4 | -158.22 Million USD | -2.95% |
| 2014 Q4 | -150.39 Million USD | -52.56% |
| 2014 Q2 | -107.28 Million USD | -116.24% |
| 2014 Q1 | -49.61 Million USD | -40.34% |
| 2014 FY | -150.39 Million USD | -325.43% |
| 2014 Q3 | -98.57 Million USD | 8.11% |
| 2013 Q4 | -35.35 Million USD | 0.0% |
| 2013 Q1 | 14.54 Million USD | 0.0% |
| 2013 FY | -35.35 Million USD | -175.96% |
| 2012 FY | -12.81 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 775.636% |
| Alkermes plc | -166.73 Million USD | 326.672% |
| Agenus Inc. | 274.13 Million USD | -37.87% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 79.788% |
| Aptorum Group Limited | 1.35 Million USD | -27751.009% |
| Ardelyx, Inc. | 34.51 Million USD | -995.129% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -8730.631% |
| Bicycle Therapeutics plc | -481.46 Million USD | 178.5% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -945.132% |
| ChromaDex Corporation | -24.04 Million USD | 1671.653% |
| Chimerix, Inc. | -25.51 Million USD | 1581.173% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -5324.037% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1696.279% |
| CRISPR Therapeutics AG | -150.84 Million USD | 350.556% |
| Precision BioSciences, Inc. | -85.41 Million USD | 542.514% |
| Dyadic International, Inc. | -6.37 Million USD | 6025.763% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 2472.127% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4830.868% |
| Lantern Pharma Inc. | -21.7 Million USD | 1841.447% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 441.923% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 4524.01% |
| Incyte Corporation | -3.17 Billion USD | 111.904% |
| IO Biotech, Inc. | -140.69 Million USD | 368.624% |
| Jaguar Health, Inc. | 29.39 Million USD | -1185.941% |
| Novavax, Inc. | -298.29 Million USD | 226.704% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -6981.713% |
| Opthea Limited | 28.15 Million USD | -1242.277% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 2351.182% |
| ContextLogic Inc. | -232 Million USD | 262.91% |
| MiMedx Group, Inc. | -33.9 Million USD | 1214.867% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -3607.219% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 16411.895% |
| NextCure, Inc. | -6.47 Million USD | 5935.279% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 848.403% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 6024.926% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -3007.315% |
| Vaxcyte, Inc. | -368.22 Million USD | 202.641% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1255.499% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -2087.47% |
| Pharming Group N.V. | 109.8 Million USD | -244.205% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 2272.632% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 315.689% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 2140.788% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 2140.788% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 5423.254% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 6549.676% |
| Acelyrin, Inc. | -216.9 Million USD | 274.249% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 6836.774% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 22022.912% |
| Summit Therapeutics Inc. | 34.67 Million USD | -990.013% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 5655.652% |
| Senti Biosciences, Inc. | 1.74 Million USD | -21621.322% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 304.733% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 587.987% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 6334.758% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -378726.088% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -60083.28% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 422.908% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 324.659% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -240.896% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 5075.658% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 392.727% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -5381.842% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 255.944% |
| Immix Biopharma, Inc. | -17.5 Million USD | 2258.512% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 219.339% |
| MEI Pharma, Inc. | -3.7 Million USD | 10301.107% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2920.95% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -133.675% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -1259.878% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4830.868% |
| Precigen, Inc. | -481 Thousand USD | 78676.091% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -2584.12% |
| AlloVir, Inc. | -62.69 Million USD | 702.87% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 779.597% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -512.9% |
| ImmuCell Corporation | 10.99 Million USD | -3338.869% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 345.19% |
| Onconetix, Inc. | 5.33 Million USD | -6989.102% |
| PureTech Health plc | -167.19 Million USD | 326.051% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 1340.811% |
| Elevation Oncology, Inc. | -19.11 Million USD | 2076.938% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 7799.144% |
| Seer, Inc. | -4.24 Million USD | 9013.939% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1672.372% |
| Innoviva, Inc. | 255.56 Million USD | -47.89% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 776.556% |
| ESSA Pharma Inc. | -33.62 Million USD | 1224.132% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1022.182% |
| GT Biopharma, Inc. | -1.02 Million USD | 37117.728% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 657.59% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -516.992% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 381.887% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2827.706% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1409.057% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 501800.427% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 1324.648% |
| Aptose Biosciences Inc. | -8.19 Million USD | 4712.051% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 12178.901% |
| Soligenix, Inc. | -4.95 Million USD | 7732.911% |
| Century Therapeutics, Inc. | 847 Thousand USD | -44522.314% |
| Kura Oncology, Inc. | -20.11 Million USD | 1978.671% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1023.499% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 4600.488% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -20647.216% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 11922.052% |
| Autolus Therapeutics plc | -186.59 Million USD | 302.547% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 866.573% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 237.041% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -1002.927% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -129.942% |
| GRI Bio, Inc. | -1.79 Million USD | 21167.503% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 4307.381% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1236.455% |
| IGM Biosciences, Inc. | -72.6 Million USD | 620.551% |
| INmune Bio, Inc. | -25.41 Million USD | 1587.352% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -150.38% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 846.069% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2425.942% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 13200.891% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -894.215% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1017.691% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -1085.357% |
| Verastem, Inc. | -37.27 Million USD | 1113.871% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 4265.667% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 828.763% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 2597.199% |
| Histogen Inc. | -7.48 Million USD | 5148.097% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1849.221% |
| Surrozen, Inc. | -32.66 Million USD | 1257.087% |
| Organovo Holdings, Inc. | -1.5 Million USD | 25179.695% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 9091.366% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1893.391% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -14347.668% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -8994.105% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 4609.536% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 970.013% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 2692.815% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 219.307% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 52443.434% |
| Apollomics, Inc. | -27.39 Million USD | 1479.635% |
| Amarin Corporation plc | -191.04 Million USD | 297.839% |
| Mesoblast Limited | 55.96 Million USD | -575.359% |
| Turnstone Biologics Corp. | -14.58 Million USD | 2691.546% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1594.35% |
| Synaptogenix, Inc. | -28.66 Million USD | 1418.671% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 40479.38% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -675.57% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 43941.297% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 5301.58% |
| Exelixis, Inc. | -73.05 Million USD | 617.387% |
| Better Therapeutics, Inc. | -860 Thousand USD | 44047.791% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1673.943% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 256.585% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -51247.434% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 5181.26% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -30039.633% |
| Gritstone bio, Inc. | 39.49 Million USD | -857.08% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 549.401% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 14459.077% |
| Avid Bioservices, Inc. | 169.72 Million USD | -122.68% |
| Insmed Incorporated | 721.62 Million USD | 47.625% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 4234.447% |
| MediWound Ltd. | -5.32 Million USD | 7201.672% |
| OmniAb, Inc. | 9.2 Million USD | -4006.824% |
| Alector, Inc. | -35.63 Million USD | 1160.558% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -339.626% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 7769.46% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -2754.83% |
| Zai Lab Limited | -775 Million USD | 148.768% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -10.981% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1855.87% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 558.234% |
| Immunic, Inc. | -45.34 Million USD | 933.593% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 295.612% |
| Veracyte, Inc. | -203.82 Million USD | 285.43% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 40.787% |
| FibroGen, Inc. | 56.76 Million USD | -565.794% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -4144.256% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 13468.944% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 18355.433% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 91.766% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 11412.511% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 327.731% |
| TG Therapeutics, Inc. | 17.86 Million USD | -2015.95% |
| Galecto, Inc. | -21.21 Million USD | 1881.443% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1689.031% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 75.917% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1644.422% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 3384.531% |
| XBiotech Inc. | -200.02 Million USD | 288.954% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 549.401% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -8246.974% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1171.806% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 589.46% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -6541.205% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 321.783% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 509.153% |
| Vaxxinity, Inc. | 10.13 Million USD | -3630.27% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 48.667% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 3610.092% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 673.035% |
| NexImmune, Inc. | -3.13 Million USD | 12161.074% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 11046.62% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 2601.09% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1494.653% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 4310.659% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 303492.334% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1031.556% |
| Ainos, Inc. | 4.07 Million USD | -9168.212% |
| Pluri Inc. | 22.82 Million USD | -1555.574% |
| Prothena Corporation plc | -608.34 Million USD | 162.128% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 418.258% |
| Celularity Inc. | 65.19 Million USD | -479.768% |
| Rallybio Corporation | -24.1 Million USD | 1668.131% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1217.57% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1037.797% |
| Omeros Corporation | 331.17 Million USD | -14.124% |
| Humacyte, Inc. | -22.48 Million USD | 1780.828% |
| Immunocore Holdings plc | -358.59 Million USD | 205.398% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1637.949% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 1323.103% |
| Blueprint Medicines Corporation | 702.83 Million USD | 46.225% |
| CalciMedica, Inc. | -5.53 Million USD | 6934.557% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 300.803% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 3800.323% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1044.004% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1236.592% |
| Pulmatrix, Inc. | -10.41 Million USD | 3728.213% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 6423.423% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1090.905% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 439.268% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 730.507% |
| Cytokinetics, Incorporated | 642.37 Million USD | 41.163% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 6590.658% |
| Nutriband Inc. | -251.65 Thousand USD | 150284.974% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1207.743% |
| Vor Biopharma Inc. | 4.3 Million USD | -8689.558% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 106.262% |
| Evogene Ltd. | -19.63 Million USD | 2024.982% |
| ProKidney Corp. | -56.23 Million USD | 772.08% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 876.527% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 4191.624% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 72.289% |
| CorMedix Inc. | -43.05 Million USD | 977.884% |
| BioLineRx Ltd. | 7.33 Million USD | -5052.004% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1476.119% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -719.015% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1423.451% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -16844.456% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1756.517% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -2031.102% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 603.438% |
| MediciNova, Inc. | -50.78 Million USD | 844.24% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 579.603% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1680255.59% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5957.354% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 289.145% |
| Biomea Fusion, Inc. | -166.57 Million USD | 326.902% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 311.175% |
| Mereo BioPharma Group plc | -51.46 Million USD | 834.327% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 498.498% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 228.66% |
| Absci Corporation | -72.59 Million USD | 620.608% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -8177.508% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 261.216% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 501.175% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 494.95% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1067.295% |
| Allakos Inc. | -24.97 Million USD | 1613.317% |
| Imunon, Inc. | -4.21 Million USD | 9069.252% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 2663.77% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 379.137% |
| BioAtla, Inc. | -109.01 Million USD | 446.709% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -51247.434% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 40350.373% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -3058.541% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1882.535% |
| XOMA Corporation | -29 Million USD | 1403.279% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 2382.313% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 4292.003% |
| aTyr Pharma, Inc. | -7.44 Million USD | 5173.849% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 403.244% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 281.564% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 562.161% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 507.437% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 44089.53% |
| Akari Therapeutics, Plc | -3.84 Million USD | 9929.675% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -23188.763% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 72.63% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 31910.442% |
| UroGen Pharma Ltd. | 4.39 Million USD | -8507.402% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -233.052% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -525109.138% |
| Orgenesis Inc. | 21.78 Million USD | -1634.994% |
| Entera Bio Ltd. | -10.62 Million USD | 3655.847% |
| GH Research PLC | -78.07 Million USD | 584.075% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1795.76% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1517.724% |
| Xencor, Inc. | 29.64 Million USD | -1174.966% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 19287.161% |
| Replimune Group, Inc. | 1.41 Million USD | -26667.068% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 154423.664% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 398.972% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 31910.442% |
| Portage Biotech Inc. | -4.98 Million USD | 7687.854% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1680255.59% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 671.596% |
| OncoCyte Corporation | -6.56 Million USD | 5858.815% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -42015.615% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 8396.326% |
| Purple Biotech Ltd. | -14.13 Million USD | 2773.299% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1690.971% |
| scPharmaceuticals Inc. | -6.54 Million USD | 5874.652% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 2364.242% |
| HilleVax, Inc. | -165.48 Million USD | 328.39% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 14991.686% |
| Tharimmune, Inc. | -10.93 Million USD | 3556.231% |
| Genprex, Inc. | -6.73 Million USD | 5709.555% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 202.479% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 527.256% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 27077.231% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 11494.548% |
| OKYO Pharma Limited | -826.84 Thousand USD | 45809.852% |
| Savara Inc. | 153 Thousand USD | -246926.797% |
| Curis, Inc. | -23.88 Million USD | 1682.246% |
| Daré Bioscience, Inc. | -5.15 Million USD | 7427.598% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 48804.273% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 6188.128% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -31794.599% |
| BeiGene, Ltd. | -2.25 Billion USD | 116.775% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2963.184% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 162.142% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 303.653% |
| Erasca, Inc. | -37.21 Million USD | 1115.561% |
| bluebird bio, Inc. | 108.57 Million USD | -248.114% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 29446.46% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 0.21% |
| DBV Technologies S.A. | -126.98 Million USD | 397.632% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 29446.46% |
| Moderna, Inc. | -2.9 Billion USD | 113.001% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 3750.995% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 3577.65% |
| Molecular Templates, Inc. | 707 Thousand USD | -53358.416% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 1304.778% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -9.043% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 560.568% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 512.026% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 1271.142% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1199.462% |
| MacroGenics, Inc. | -66.98 Million USD | 664.232% |
| RenovoRx, Inc. | -1.17 Million USD | 32320.887% |
| Adicet Bio, Inc. | -138.78 Million USD | 372.324% |
| Prime Medicine, Inc. | -27.94 Million USD | 1452.675% |
| Aditxt, Inc. | 18.12 Million USD | -1985.72% |
| Adagene Inc. | -87.62 Million USD | 531.316% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 9173.521% |
| Quantum-Si incorporated | -118.55 Million USD | 418.793% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -949.718% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 5156.75% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 879.136% |
| SciSparc Ltd. | -2.06 Million USD | 18402.712% |
| Vericel Corporation | 1.27 Million USD | -29496.789% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 3251.771% |
| Minerva Neurosciences, Inc. | 41 Million USD | -821.736% |
| Generation Bio Co. | 31.44 Million USD | -1101.828% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 315.524% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 1322.233% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -224.163% |
| Invivyd, Inc. | -198.47 Million USD | 290.427% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 518.689% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 15863.142% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 633.905% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 5637.744% |
| 2seventy bio, Inc. | 181.71 Million USD | -107.991% |
| ADMA Biologics, Inc. | 90.06 Million USD | -319.638% |
| Clene Inc. | 3.34 Million USD | -11215.898% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 4261.217% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1857.013% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5957.354% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 209.83% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1553.675% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -112.731% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 9337.317% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -7455.998% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 7355.73% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 390.053% |
| Evaxion Biotech A/S | 5.28 Million USD | -7048.896% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 435.754% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 387.912% |
| Trevena, Inc. | 2.25 Million USD | -16638.308% |
| Surrozen, Inc. | -32.66 Million USD | 1257.087% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 833.743% |
| Cingulate Inc. | 3.08 Million USD | -12160.456% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 12968.607% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -5158.815% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 4167.827% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 576.471% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 387.52% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 458.105% |
| Clearmind Medicine Inc. | -3.94 Million USD | 9686.249% |
| Kronos Bio, Inc. | -36.05 Million USD | 1148.291% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -3916.909% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -25820.307% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 796.607% |
| Statera Biopharma, Inc. | 14.41 Million USD | -2521.673% |
| ImmunityBio, Inc. | 618.22 Million USD | 38.865% |
| Korro Bio, Inc. | -132.94 Million USD | 384.296% |
| Kineta, Inc. | -4.54 Million USD | 8423.079% |
| BioVie Inc. | -17.73 Million USD | 2231.421% |
| Codexis, Inc. | -43.27 Million USD | 973.451% |
| Celularity Inc. | 65.19 Million USD | -479.768% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 12026.507% |
| Celcuity Inc. | 6.78 Million USD | -5471.615% |
| Virax Biolabs Group Limited | -3.36 Million USD | 11332.015% |
| Cibus, Inc. | -8.07 Million USD | 4778.769% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 9037.125% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -8170.263% |
| IN8bio, Inc. | -16.38 Million USD | 2406.126% |
| Kodiak Sciences Inc. | -103.87 Million USD | 463.852% |
| Annexon, Inc. | -193.75 Million USD | 295.066% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -1049763.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 2259.843% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 10858.639% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 64.151% |
| Eyenovia, Inc. | 1.25 Million USD | -29927.044% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -1304.761% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 11754.363% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1236.797% |
| Arcellx, Inc. | -296.95 Million USD | 227.274% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 2037.614% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 741.955% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1923.472% |
| Moolec Science SA | 117.61 Thousand USD | -321243.185% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1084.273% |
| Geron Corporation | 14.76 Million USD | -2460.47% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1096.759% |
| Royalty Pharma plc | 5.65 Billion USD | 93.32% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 367.252% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 5507.47% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 7147.565% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 368.563% |
| Humacyte, Inc. | -22.48 Million USD | 1780.828% |
| Structure Therapeutics Inc. | -124.33 Million USD | 403.968% |
| 89bio, Inc. | -289.05 Million USD | 230.755% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1597.31% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 21297.476% |
| Genelux Corporation | -6.89 Million USD | 5578.345% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 1316.881% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -352.1% |
| Notable Labs, Ltd. | -9.77 Million USD | 3966.111% |
| Liquidia Corporation | -80.17 Million USD | 571.402% |
| Mustang Bio, Inc. | -3.73 Million USD | 10216.461% |
| Immunovant, Inc. | -635.22 Million USD | 159.499% |
| Quantum-Si incorporated | -118.55 Million USD | 418.793% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 2251.85% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 9222.641% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -4608.496% |
| Acasti Pharma Inc. | -23 Million USD | 1742.908% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 11324.393% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2425.942% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 374.395% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 12227.956% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1800.031% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 2135.387% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 323.272% |
| PepGen Inc. | -60.67 Million USD | 722.962% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1744.982% |
| United Therapeutics Corporation | -507.7 Million USD | 174.444% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 2076.111% |
| Solid Biosciences Inc. | -47.75 Million USD | 891.52% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 43941.297% |
| Immuneering Corporation | -54.94 Million USD | 787.898% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 9091.366% |
| Silo Pharma, Inc. | -3.52 Million USD | 10824.119% |
| Belite Bio, Inc | -87.27 Million USD | 533.077% |
| XOMA Corporation | -29 Million USD | 1403.279% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 634.607% |
| Bionomics Limited | 227 Million USD | -66.491% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 425.03% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 15021.082% |
| uniQure N.V. | -102.95 Million USD | 467.117% |
| Cassava Sciences, Inc. | -121.13 Million USD | 412.006% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 9173.521% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -822.935% |
| Forte Biosciences, Inc. | -11.96 Million USD | 3259.861% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 12314.821% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -356457.547% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 11754.363% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -4144.256% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 5196.427% |
| Altimmune, Inc. | -134.48 Million USD | 381.032% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -90.822% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 15021.082% |
| Compugen Ltd. | -12.9 Million USD | 3028.945% |
| Peak Bio, Inc. | 10.34 Million USD | -3555.176% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 133651.59% |
| Benitec Biopharma Inc. | -50.58 Million USD | 847.205% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 462.237% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1823.904% |
| Zura Bio Limited | -99.8 Million USD | 478.686% |
| PolyPid Ltd. | 6.17 Million USD | -6025.624% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -409.918% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1823.904% |
| Instil Bio, Inc. | 75.35 Million USD | -401.541% |
| argenx SE | -2.02 Billion USD | 118.629% |
| Immunome, Inc. | -97.02 Million USD | 489.524% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1780.156% |
| Verona Pharma plc | -220.44 Million USD | 271.451% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 626.812% |
| Shattuck Labs, Inc. | -121.42 Million USD | 411.265% |
| CervoMed Inc. | -7.79 Million USD | 4949.974% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 303.748% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 8742.831% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 386.892% |
| Moolec Science SA | 117.61 Thousand USD | -321243.185% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 16619.003% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -2277.293% |
| AnaptysBio, Inc. | -18.15 Million USD | 2182.26% |
| Design Therapeutics, Inc. | -18.15 Million USD | 2182.375% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 637.007% |
| NeurAxis, Inc. | 145.7 Thousand USD | -259303.569% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -3264.948% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1426.47% |
| Achilles Therapeutics plc | -126.92 Million USD | 397.777% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 626.812% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 57738.205% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1919.362% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -25820.307% |
| Nutriband Inc. | -251.65 Thousand USD | 150284.974% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2969.57% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 5179.987% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -11.098% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1492.378% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 184.464% |
| Palisade Bio, Inc. | -12.06 Million USD | 3233.143% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 369.367% |
| Beam Therapeutics Inc. | -262.72 Million USD | 243.86% |
| Neurogene Inc. | -131.95 Million USD | 386.424% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1632.449% |
| AEON Biopharma, Inc. | -4.88 Million USD | 7844.898% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 200.201% |
| Sesen Bio, Inc. | -112.55 Million USD | 435.798% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 478.481% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 16198.14% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1068.459% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 553.821% |
| Athira Pharma, Inc. | -88.99 Million USD | 524.669% |
| Vaccinex, Inc. | -1.28 Million USD | 29444.022% |
| HCW Biologics Inc. | 2.85 Million USD | -13130.447% |
| XOMA Corporation | -29 Million USD | 1403.279% |
| Nektar Therapeutics | 210.24 Million USD | -79.771% |
| Arvinas, Inc. | -313.8 Million USD | 220.443% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -23188.763% |
| Merus N.V. | -192.88 Million USD | 295.947% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -530.076% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 5547.55% |
| Rezolute, Inc. | -68.16 Million USD | 654.44% |
| Clene Inc. | 3.34 Million USD | -11215.898% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2966.088% |
| BeyondSpring Inc. | -13.75 Million USD | 2847.735% |
| Synlogic, Inc. | -6.68 Million USD | 5753.717% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -33229.012% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 4570.148% |
| Peak Bio, Inc. | 10.34 Million USD | -3555.176% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 558.567% |
| Krystal Biotech, Inc. | -350.23 Million USD | 207.914% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -204.492% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 323.645% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 12071.294% |
| MannKind Corporation | 143.89 Million USD | -162.65% |
| Ikena Oncology, Inc. | -109.15 Million USD | 446.248% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 5092.088% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1241.846% |
| Gossamer Bio, Inc. | 180.35 Million USD | -109.559% |
| CohBar, Inc. | -5.93 Million USD | 6472.756% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1370.509% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -8177.508% |
| Legend Biotech Corporation | -949.39 Million USD | 139.81% |
| Mural Oncology plc | -255.84 Million USD | 247.728% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -1073.214% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 8123.344% |
| Disc Medicine, Inc. | -358.28 Million USD | 205.49% |
| Champions Oncology, Inc. | 4.81 Million USD | -7754.343% |
| REGENXBIO Inc. | 54.76 Million USD | -590.095% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 140650.822% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 350.259% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 4293.861% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 568.439% |
| Vaxart, Inc. | -8.24 Million USD | 4686.227% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 853.191% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 397.212% |
| Cellectis S.A. | -43.85 Million USD | 961.82% |
| Longeveron Inc. | -2.9 Million USD | 13096.939% |
| Repare Therapeutics Inc. | -107.85 Million USD | 450.415% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 60.971% |
| Inozyme Pharma, Inc. | 12 Million USD | -3048.542% |
| Revolution Medicines, Inc. | -608.2 Million USD | 162.142% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 30827.724% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 242.56% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 351.846% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 2515.485% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 51174.459% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 103.952% |
| Denali Therapeutics Inc. | -74.86 Million USD | 604.843% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 3251.771% |
| Veru Inc. | 4.77 Million USD | -7806.976% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 3460.759% |
| Cingulate Inc. | 3.08 Million USD | -12160.456% |
| Passage Bio, Inc. | 4.58 Million USD | -8143.206% |
| Context Therapeutics Inc. | -14.44 Million USD | 2715.609% |
| Exicure, Inc. | 5.84 Million USD | -6361.805% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 264.058% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1055.145% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -2308.712% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 742.544% |
| Nuvalent, Inc. | -335.38 Million USD | 212.691% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -21692.197% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 607.439% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 4351.417% |
| OmniAb, Inc. | 9.2 Million USD | -4006.824% |
| Anew Medical, Inc. | 1.43 Million USD | -26284.659% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -2207.146% |
| Lipocine Inc. | -4.75 Million USD | 8049.178% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 444.13% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -2381.459% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 846.069% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1418.363% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 5723.434% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 674.158% |
| Ocugen, Inc. | -32.52 Million USD | 1262.175% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 541.661% |
| Q32 Bio Inc. | -37.94 Million USD | 1095.971% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 60283.28% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2893.636% |
| Equillium, Inc. | -22.39 Million USD | 1787.884% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1578.219% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1258.408% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 152551.848% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -181.965% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -11718.355% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -114974.245% |
| Dominari Holdings Inc. | 195 Thousand USD | -193721.026% |
| Edesa Biotech, Inc. | -5.26 Million USD | 7275.953% |
| vTv Therapeutics Inc. | -8.91 Million USD | 4338.544% |
| Bio-Techne Corporation | 267.74 Million USD | -41.16% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 2431.735% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 420.043% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 4597.81% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 3087.519% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 254.191% |
| Nkarta, Inc. | 57.29 Million USD | -559.612% |
| BioCardia, Inc. | 212 Thousand USD | -178178.774% |
| Iterum Therapeutics plc | 13.43 Million USD | -2712.554% |